These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 25224029

  • 21. Varicella vaccines and measles, mumps, rubella, and varicella vaccine.
    Bricks LF, Sato HK, Oselka GW.
    J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S101-8. PubMed ID: 16826308
    [Abstract] [Full Text] [Related]

  • 22. Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age.
    Vesikari T, Becker T, Gajdos V, Fiquet A, Thomas S, Richard P, Baudin M.
    Vaccine; 2012 Apr 26; 30(20):3082-9. PubMed ID: 22406278
    [Abstract] [Full Text] [Related]

  • 23. A combination vaccine against measles, mumps, rubella and varicella.
    Knuf M, Faber J, Barth I, Habermehl P.
    Drugs Today (Barc); 2008 Apr 26; 44(4):279-92. PubMed ID: 18536786
    [Abstract] [Full Text] [Related]

  • 24. Immunity of nursing students to measles, mumps, rubella, and varicella in Yozgat, Turkey.
    Kader Ç, Erbay A, Akça NK, Polat MF, Polat S.
    Am J Infect Control; 2016 Jan 01; 44(1):e5-7. PubMed ID: 26442461
    [Abstract] [Full Text] [Related]

  • 25. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial.
    Lalwani S, Chatterjee S, Balasubramanian S, Bavdekar A, Mehta S, Datta S, Povey M, Henry O.
    BMJ Open; 2015 Sep 11; 5(9):e007202. PubMed ID: 26362659
    [Abstract] [Full Text] [Related]

  • 26. Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel.
    Rosario-Rosario G, Gareca M, Kincaid H, Knouse MC.
    J Travel Med; 2015 Sep 11; 22(6):396-402. PubMed ID: 26412393
    [Abstract] [Full Text] [Related]

  • 27. [Antibody titers against measles, rubella, mumps and varicella-zoster viruses in medical students].
    Yoshida N, Tsumura N, Toyomasu K, Sagawa K.
    Sangyo Eiseigaku Zasshi; 2007 Jan 11; 49(1):21-6. PubMed ID: 17303935
    [Abstract] [Full Text] [Related]

  • 28. Prospective Study of Live Attenuated Vaccines for Patients with Nephrotic Syndrome Receiving Immunosuppressive Agents.
    Kamei K, Miyairi I, Ishikura K, Ogura M, Shoji K, Funaki T, Ito R, Arai K, Abe J, Kawai T, Onodera M, Ito S.
    J Pediatr; 2018 May 11; 196():217-222.e1. PubMed ID: 29499990
    [Abstract] [Full Text] [Related]

  • 29. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella.
    Ramet J.
    Int J Infect Dis; 2007 Nov 11; 11 Suppl 2():S49-55. PubMed ID: 18162247
    [Abstract] [Full Text] [Related]

  • 30. Immunogenicity and safety of combined measles-mumps-rubella-varicella vaccine using new measles and rubella working seeds in healthy children in Taiwan and Singapore: a phase II, randomized, double-blind trial.
    Huang LM, Lee BW, Chan PC, Povey M, Henry O.
    Hum Vaccin Immunother; 2013 Jun 11; 9(6):1308-15. PubMed ID: 23425607
    [Abstract] [Full Text] [Related]

  • 31. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V.
    Cochrane Database Syst Rev; 2021 Nov 22; 11(11):CD004407. PubMed ID: 34806766
    [Abstract] [Full Text] [Related]

  • 32. The evolution of vaccines for early childhood: the MMRV.
    Ferrera G, Squeri R, Genovese C.
    Ann Ig; 2018 Nov 22; 30(4 Supple 1):33-37. PubMed ID: 30062378
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Combination Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children: A Systematic Review and Meta-analysis of Immunogenicity and Safety.
    Ma SJ, Li X, Xiong YQ, Yao AL, Chen Q.
    Medicine (Baltimore); 2015 Nov 22; 94(44):e1721. PubMed ID: 26554769
    [Abstract] [Full Text] [Related]

  • 37. [Vaccination against rubella, measles, chickenpox, and mumps in nursing students].
    Tashiro T, Urata H, Okada J, Iwanaga K, Tokunaga M, Matsumoto T.
    Kansenshogaku Zasshi; 2004 May 22; 78(5):398-403. PubMed ID: 15211861
    [Abstract] [Full Text] [Related]

  • 38. Seroprevalence of Measles, Mumps, Rubella, and Varicella-Zoster Virus and Seroresponse to the Vaccinations in Adult Solid Organ Transplant Candidates.
    Javaid H, Prasad P, De Golovine A, Hasbun R, Jyothula S, Machicao V, Bynon JS, Ostrosky L, Nigo M.
    Transplantation; 2023 Oct 01; 107(10):2279-2284. PubMed ID: 37309028
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunogenicity and safety of intramuscular versus subcutaneous administration of a combined measles, mumps, rubella, and varicella vaccine to children 12 to 18 months of age.
    Haas H, Richard P, Eymin C, Fiquet A, Kuter B, Soubeyrand B.
    Hum Vaccin Immunother; 2019 Oct 01; 15(4):778-785. PubMed ID: 30481110
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.